neostigmine has been researched along with Cystic Fibrosis of Pancreas in 2 studies
Neostigmine: A cholinesterase inhibitor used in the treatment of myasthenia gravis and to reverse the effects of muscle relaxants such as gallamine and tubocurarine. Neostigmine, unlike PHYSOSTIGMINE, does not cross the blood-brain barrier.
neostigmine : A quaternary ammonium ion comprising an anilinium ion core having three methyl substituents on the aniline nitrogen, and a 3-[(dimethylcarbamoyl)oxy] substituent at position 3. It is a parasympathomimetic which acts as a reversible acetylcholinesterase inhibitor.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| PALMER, HD | 1 |
| DANIELSON, WH | 1 |
| Kurtzman, TL | 1 |
| Borowitz, SM | 1 |
2 other studies available for neostigmine and Cystic Fibrosis of Pancreas
| Article | Year |
|---|---|
Absorption of vitamin A following enteral use of prostigmine in cystic fibrosis of pancreas.
Topics: Cystic Fibrosis; Humans; Neostigmine; Pancreas; Vitamin A; Vitamins | 1946 |
Successful use of neostigmine in a patient with refractory distal intestinal obstruction syndrome.
Topics: Adult; Cholinesterase Inhibitors; Cystic Fibrosis; Female; Humans; Injections, Intravenous; Intestin | 2002 |